Enzalutamide (Xtandi)

enzalutamide · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Enzalutamide (Xtandi), covering 2015-01-26 to 2023-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer [Phase 2]